A Study Measuring Effect of LY2140023 (Pomaglumetad Methionil) on Electrocardiographs in Participants With Schizophrenia

Clinical trial NCT01606436 · COMPLETED

Trial details

NCT number: NCT01606436
Sponsor: Denovo Biopharma LLC
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Schizophrenic Disorders

Start date: 2012-06-01
Primary completion: 2012-08-01
Enrollment: 86

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.